Upgrade to SI Premium - Free Trial

AcelRx Pharma (ACRX) Receives Positive CHMP Opinion for DZUVEO for Management of Pain

April 27, 2018 7:21 AM
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles